Education
About Us
Working with TipRanks
Follow Us
Nephros Inc (NEPH)
NASDAQ:NEPH
NEPH Stock Chart & Stats
$5.01
<$0.01(0.48%)
At close: 4:00 PM EST
$5.01
<$0.01(0.48%)
Day’s Range― - ―
52-Week Range$1.49 - $6.42
Previous Close$1.57
Volume70.00
Average Volume (3M)75.62K
Market Cap
$30.97M
Enterprise Value$26.64M
Total Cash (Recent Filing)$5.40M
Total Debt (Recent Filing)$1.06M
Price to Earnings (P/E)43.4
Beta-0.39
Next Earnings
May 07, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding10,644,268
10 Day Avg. Volume107,933
30 Day Avg. Volume75,620
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)5.08
Price to Sales (P/S)2.76
P/FCF Ratio31.48
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue1.42
Enterprise Value/Gross Profit2.32
Enterprise Value/Ebitda20.71
Forecast
1Y Price Target
$8.00Price Target Upside59.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.06
Revenue Forecast (FY)$20.78M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsConsistently strong gross margins (~61–62%) reflect favorable product economics for Nephros's filtration devices and consumables. Durable product-level margins support reinvestment in R&D, services and go-to-market efforts, and provide a cushion against cost shocks over the medium term.
Recurring, Installed-Base RevenueA programmatic model (>90% of revenue) with ~1,681 active sites creates predictable, repeatable demand from consumable replacements and service programs. This installed-base-driven revenue mix increases revenue visibility and customer retention, underpinning steady cashflows as the base grows.
Conservative Leverage And LiquidityLow leverage, improved equity and a cash balance (~$5.4M) provide financial flexibility. A conservative balance sheet reduces refinancing and solvency risk, allowing the company to fund product, services and education initiatives and to absorb near-term turbulence while scaling.
Bears Say
Historical Profitability VolatilityDespite a 2024–25 turnaround, the company’s multi-year history of losses and uneven cash generation weakens confidence in sustained profitability. Small absolute scale means adverse demand or one-off costs could quickly reverse earnings progress, challenging durability of margins.
Working Capital And Cash Flow VariabilityFree cash flow volatility and a notable working-capital build reduced cash conversion in 2025. As Nephros scales, elevated receivables and inventory requirements can strain liquidity and limit reinvestment capacity unless working-capital efficiency improves and conversion stabilizes.
Structural Cost HeadwindsSustained tariff exposure and rising R&D/SG&A create structural pressure on margins. If import tariffs persist or operating spend remains elevated to support growth, it could erode the benefit of high gross margins and delay establishment of reliably higher net margins.
Nephros News
NEPH FAQ
What was Nephros Inc’s price range in the past 12 months?
Nephros Inc lowest stock price was $1.49 and its highest was $6.42 in the past 12 months.
What is Nephros Inc’s market cap?
Nephros Inc’s market cap is $30.97M.
When is Nephros Inc’s upcoming earnings report date?
Nephros Inc’s upcoming earnings report date is May 07, 2026 which is in 45 days.
How were Nephros Inc’s earnings last quarter?
Nephros Inc released its earnings results on Mar 12, 2026. The company reported $0.01 earnings per share for the quarter, the consensus estimate of $0.01 by $0.
Is Nephros Inc overvalued?
According to Wall Street analysts Nephros Inc’s price is currently Undervalued.
Does Nephros Inc pay dividends?
Nephros Inc does not currently pay dividends.
What is Nephros Inc’s EPS estimate?
Nephros Inc’s EPS estimate is 0.01.
How many shares outstanding does Nephros Inc have?
Nephros Inc has 10,644,268 shares outstanding.
What happened to Nephros Inc’s price movement after its last earnings report?
Nephros Inc reported an EPS of $0.01 in its last earnings report, expectations of $0.01. Following the earnings report the stock price went down -7.895%.
Which hedge fund is a major shareholder of Nephros Inc?
Currently, no hedge funds are holding shares in NEPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nephros Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (59.68% Upside)
$8.00 (59.68% Upside)
Hedge Fund Trend
Decreased
By 5.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
226.00%
12-Months-Change
Fundamentals
Return on Equity
12.22%
Trailing 12-Months
Asset Growth
21.69%
Trailing 12-Months
Company Description
Nephros Inc
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
NEPH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a largely positive operational and financial story: solid top-line growth (+33% FY), return to full-year profitability (~$1.2M), improved full-year adjusted EBITDA and positive operating cash flow, expansion of product/service/education initiatives, and an increased active site base. Near-term headwinds were highlighted—most notably Q4 margin compression (58% vs 64% prior-year quarter) driven by import tariffs, higher quarterly SG&A and R&D spend, one-time Q4 expenses, and working capital build that pressured quarterly EBITDA and net income. On balance, the company appears to be scaling with improving annual profitability and cash generation, while managing near-term cost and tariff-related margin challenges.View all NEPH earnings summariesNEPH Stock 12 Month Forecast
Average Price Target
$8.00
▲(59.68% Upside)
Technical Analysis
Ownership Overview
2.40% Insiders
2.40% Mutual Funds
42.98% Other Institutional Investors
50.28% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---